My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 780

    1.

    Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.

    Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH; EURODIAB IDDM Complications Study Group.

    Diabetes Care. 2001 Feb;24(2):316-22. Erratum in: Diabetes Care 2001 May;24(5):973. Georgino, F [corrected to Giorgino, F]. PMID: 11213885 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.

    Nayak SB, Bhaktha G.

    Lipids Health Dis. 2005 Aug 10;4:15.PMID: 16092968 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).

    Soedamah-Muthu SS, Chaturvedi N, Pickup JC, Fuller JH; EURODIAB Prospective Complications Study Group.

    Diabetologia. 2008 Mar;51(3):493-501. Epub 2008 Jan 9.PMID: 18183363 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.

    Abdella N, Akanji AO, Mojiminiyi OA, Al Assoussi A, Moussa M.

    Diabetes Res Clin Pract. 2000 Sep;50(1):65-72.PMID: 10936670 [PubMed - indexed for MEDLINE]Related articles

    5.

    Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.

    Yokoyama H, Jensen JS, Jensen T, Deckert T.

    J Intern Med. 1995 May;237(5):519-23.PMID: 7738493 [PubMed - indexed for MEDLINE]Related articles

    6.

    Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.

    Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH.

    Diabetes Care. 1996 Feb;19(2):130-4.PMID: 8718432 [PubMed - indexed for MEDLINE]Related articles

    7.

    Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.

    Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD; Eurodiab ProspectivE Complications Study Group.

    J Intern Med. 2005 Nov;258(5):450-9.PMID: 16238681 [PubMed - indexed for MEDLINE]Related articles

    8.

    The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.

    Davies L, Fulcher GR, Atkins A, Frumar K, Monaghan J, Stokes G, Clifton-Bligh P, McElduff A, Robinson B, Stiel J, Twigg S, Wilmshurst E.

    J Diabetes Complications. 1999 Jan-Feb;13(1):45-51.PMID: 10232709 [PubMed - indexed for MEDLINE]Related articles

    9.

    Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.

    Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM, Fuller JH.

    Diabetologia. 1997 Jun;40(6):698-705.PMID: 9222650 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.

    Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, Garvey WT; DCCT/ECIC STUDY GROUP.

    Diabetes Care. 2003 May;26(5):1439-48.PMID: 12716802 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.

    Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B.

    Diabetes Care. 1996 Jul;19(7):689-97.PMID: 8799621 [PubMed - indexed for MEDLINE]Related articles

    12.

    Serum sialic acid concentration and coronary heart disease in NIDDM.

    Pickup JC, Mattock MB, Crook MA, Chusney GD, Burt D, Fitzgerald AP.

    Diabetes Care. 1995 Aug;18(8):1100-3.PMID: 7587844 [PubMed - indexed for MEDLINE]Related articles

    13.

    Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.

    Ebeling P, Koivisto VA.

    Acta Diabetol. 1997 Mar;34(1):33-8.PMID: 9134055 [PubMed - indexed for MEDLINE]Related articles

    14.

    Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.

    Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R.

    Diabetes Nutr Metab. 2002 Aug;15(4):232-9.PMID: 12416660 [PubMed - indexed for MEDLINE]Related articles

    15.

    Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus.

    Powrie JK, Watts GF, Crook MA, Ingham JN, Taub NA, Shaw KM.

    Diabet Med. 1996 Mar;13(3):238-42.PMID: 8689844 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications]

    Spunda J, Neumann M, Bartásková D, Kvapil M.

    Cas Lek Cesk. 1996 Nov 20;135(22):723-5. Czech. PMID: 8998824 [PubMed - indexed for MEDLINE]Related articles

    17.

    Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.

    Sjølie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, Fuller J.

    Ophthalmology. 1997 Feb;104(2):252-60.PMID: 9052629 [PubMed - indexed for MEDLINE]Related articles

    18.

    Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.

    Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH; EURODIAB Prospective Complications Study Group.

    Diabetes Care. 2004 Feb;27(2):530-7.PMID: 14747240 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.

    Mattock MB, Cronin N, Cavallo-Perin P, Idzior-Walus B, Penno G, Bandinelli S, Standl E, Kofinis A, Fuller JH; EURODIAB IDDM Complications Study.

    Diabet Med. 2001 Jan;18(1):59-67.PMID: 11168343 [PubMed - indexed for MEDLINE]Related articles

    20.

    Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.

    Diabetes Care. 1996 Dec;19(12):1382-7.PMID: 8941468 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity